ABOUT

Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates with the potential to improve the lives of patients and their families. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the broader healthcare system.

Roivant delivers R&D solutions to its industry partners by helping them unlock value from their pipelines and realize the full potential of their research by completing the product development cycle. Roivant’s clinical development pipeline spans multiple therapeutic areas through strategic alliances, collaborations, and partnerships with academic institutions and pharmaceutical companies, including Takeda Pharmaceuticals, Eisai, GlaxoSmithKline, Vertex Pharmaceuticals, Arena Pharmaceuticals, Portola Pharmaceuticals, Duke University, and Cincinnati Children’s Hospital.